Search Results 51-60 of 16493 for Strontium-89
Koch AT, Keuseman RL, Parikh R, Legler SR, Ayanian S, Boyapati RB, Fischer KM, Lawson DK, Dugani SB, Burton MC, Pagali SR. Innovative telehospitalist model ...
Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.
Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.
Patients were divided by rhythm ( AFib versus SR ) at the time of transthoracic echocardiogram showing severe AS . Propensity matching was used to match 89 ...
A member of the nuclear medicine therapy team talks with a woman before she begins intravenous peptide receptor radionuclide therapy (PRRT).
The primary purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with pancreatic adenocarcinoma with ...
Publications. Print. Beriault DR, Chen Y, Yip P, Blasutig I, Bhayana V, Rutledge AC, Parker M, Kinniburgh D, Thomas D, Colbourne P, Langman L, Delaney SR ...
2023 Feb; 132:89-101 Epub 2022 July 06. View ... SR. Induction versus no induction chemotherapy ... SR, Olnes MJ. Molecular Classification of Gastric ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.